ES2141787T3 - Derivados de la 1,2,3,4-tetrahidro-9-acridinamina. - Google Patents

Derivados de la 1,2,3,4-tetrahidro-9-acridinamina.

Info

Publication number
ES2141787T3
ES2141787T3 ES94112223T ES94112223T ES2141787T3 ES 2141787 T3 ES2141787 T3 ES 2141787T3 ES 94112223 T ES94112223 T ES 94112223T ES 94112223 T ES94112223 T ES 94112223T ES 2141787 T3 ES2141787 T3 ES 2141787T3
Authority
ES
Spain
Prior art keywords
acridinamine
tetrahydro
derivatives
agents
cerebral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94112223T
Other languages
English (en)
Inventor
Colin Granger
Jeffrey Alan Kester
Walter Hamilton Moos
Anthony Jerome Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of ES2141787T3 publication Critical patent/ES2141787T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

SE PRESENTAN NUEVAS PRODROGAS O DERIVADOS DE LA 1,2,3,4-TETRAHIDRO9-ACRIDINAMINA DE LA FORMULA I ASI COMO METODOS PARA LA PREPARACION DE LOS MISMOS Y COMPOSICIONES FARMACEUTICAS OBTENIDAS A PARTIR DE LOS MISMOS, QUE SON UTILES COMO AGENTES ANALGESICOS PARA EL TRATAMIENTO DEL DOLOR, COMO AYUDA PARA EL SUEÑO Y COMO AGENTES PARA EL TRATAMIENTO DE SINTOMAS PARA LA DEMENCIA SENIL, LA ENFERMEDAD DE ALZHEIMER, EL BAILE DE SANVITO, MANIAS O CONDICIONES SIMILARES DE INSUFICIENCIA CEREBRAL QUE SE CARACTERIZAN POR UN DESCENSO DE LA PRODUCCION DE LA ACETILCOLEINA CEREBRAL.
ES94112223T 1989-07-31 1990-07-30 Derivados de la 1,2,3,4-tetrahidro-9-acridinamina. Expired - Lifetime ES2141787T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/387,722 US4999430A (en) 1989-07-31 1989-07-31 Derivatives of 1,2,3,4-tetrahydro-9-acrisinamine

Publications (1)

Publication Number Publication Date
ES2141787T3 true ES2141787T3 (es) 2000-04-01

Family

ID=23531113

Family Applications (2)

Application Number Title Priority Date Filing Date
ES90114586T Expired - Lifetime ES2068955T3 (es) 1989-07-31 1990-07-30 Derivados de 1,2,3,4-tetrahidro-9-acridinamina.
ES94112223T Expired - Lifetime ES2141787T3 (es) 1989-07-31 1990-07-30 Derivados de la 1,2,3,4-tetrahidro-9-acridinamina.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES90114586T Expired - Lifetime ES2068955T3 (es) 1989-07-31 1990-07-30 Derivados de 1,2,3,4-tetrahidro-9-acridinamina.

Country Status (17)

Country Link
US (1) US4999430A (es)
EP (2) EP0628548B1 (es)
JP (1) JP2930245B2 (es)
KR (1) KR910002802A (es)
AT (2) ATE119885T1 (es)
AU (1) AU5994590A (es)
CA (1) CA2022297C (es)
DE (2) DE69033369T2 (es)
DK (2) DK0411534T3 (es)
ES (2) ES2068955T3 (es)
FI (1) FI903752A0 (es)
GR (1) GR3032539T3 (es)
IE (1) IE66823B1 (es)
NO (1) NO903359L (es)
NZ (1) NZ234672A (es)
PT (1) PT94849A (es)
ZA (1) ZA905978B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85741A (en) * 1987-03-17 1996-05-14 Hoechst Roussel Pharma Transformed Tetra-Hydroacridines Process for their preparation and pharmaceutical preparations containing A-amino-Tetra-Transformed Hydroacridines
FR2640508B1 (fr) * 1988-12-19 1994-07-01 Dietlin Francois Nouvelles compositions et nouveaux produits pharmaceutiques assurant la regeneration de leucocytes et leur emploi pour le traitement du syndrome immuno-deficitaire
JP2546919B2 (ja) * 1989-11-08 1996-10-23 三菱化学株式会社 ９ーアシルアミノテトラヒドロアクリジン誘導体
CA2029497C (en) * 1989-11-08 2002-06-04 Kunihiro Ninomiya (Deceased) 4-acylaminopyridine derivative
US5179100A (en) * 1992-03-09 1993-01-12 Hoechst-Roussel Pharmaceuticals Inc. 4,5-dihydropyrazolo[3,4-a]acridines
US5422350A (en) * 1992-09-10 1995-06-06 Warner-Lambert Company Nitrogen substituted acridine and cytochrome P450 inhibitors and methods of use
US5466696A (en) * 1992-09-10 1995-11-14 Warner Lambert Company Tacrine and cytochrome P450 oxidase inhibitors and methods of use
HU213107B (en) * 1994-02-23 1997-02-28 Egyt Gyogyszervegyeszeti Gyar Process for producing acetic acid derivatives and pharmaceutical compositions containing them
GB9716879D0 (en) * 1997-08-08 1997-10-15 Shire Int Licensing Bv Treatment of attention deficit disorders
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
ES2168926B1 (es) * 1999-12-14 2003-10-16 Prous Science S A Derivados de ciclopenta- ciclohexa- y ciclohepta (b)quinoleina, procedimiento para su fabricacion, utilizacion y composicion farmaceutica correspondiente.
US20080045500A1 (en) * 2004-07-01 2008-02-21 Eisai R&D Management Co., Ltd. Nerve Regeneration Stimulator
CN1315810C (zh) * 2004-08-30 2007-05-16 北京理工大学 哌嗪桥联他克林双体衍生物及其合成方法
US20080188510A1 (en) * 2005-05-23 2008-08-07 Eisai R & D Management Co., Ltd. Novel methods using zonisamide
JP2013513588A (ja) * 2009-12-11 2013-04-22 ジーンコード エーエス Ｇｄｎｆファミリーリガンド（ｇｆｌ）のミメティックまたはｒｅｔシグナル経路活性化因子を用いた、神経系細胞の生存を容易にするための方法
CA2789014C (en) 2010-02-09 2019-01-15 Michela Gallagher Methods and compositions for improving cognitive function
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
CA2904767C (en) 2013-03-15 2022-06-21 Agenebio, Inc. Methods and compositions for improving cognitive function
WO2016191288A1 (en) 2015-05-22 2016-12-01 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985430A (en) * 1987-12-03 1991-01-15 Mitsubishi Kasei Corporation 9-acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient

Also Published As

Publication number Publication date
EP0628548A1 (en) 1994-12-14
AU5994590A (en) 1991-01-31
NO903359L (no) 1991-02-01
JP2930245B2 (ja) 1999-08-03
DE69017789T2 (de) 1995-07-13
JPH0366670A (ja) 1991-03-22
US4999430A (en) 1991-03-12
IE902751A1 (en) 1991-02-27
NO903359D0 (no) 1990-07-30
DK0628548T3 (da) 2000-05-08
EP0411534A3 (en) 1991-06-05
DK0411534T3 (da) 1995-07-24
FI903752A0 (fi) 1990-07-27
EP0411534B1 (en) 1995-03-15
DE69017789D1 (de) 1995-04-20
DE69033369D1 (de) 1999-12-30
GR3032539T3 (en) 2000-05-31
DE69033369T2 (de) 2000-05-11
NZ234672A (en) 1991-11-26
ES2068955T3 (es) 1995-05-01
IE66823B1 (en) 1996-02-07
PT94849A (pt) 1991-04-18
ATE186908T1 (de) 1999-12-15
KR910002802A (ko) 1991-02-26
CA2022297C (en) 2001-09-18
ZA905978B (en) 1992-04-29
EP0411534A2 (en) 1991-02-06
ATE119885T1 (de) 1995-04-15
EP0628548B1 (en) 1999-11-24
CA2022297A1 (en) 1991-02-01

Similar Documents

Publication Publication Date Title
ES2141787T3 (es) Derivados de la 1,2,3,4-tetrahidro-9-acridinamina.
IT1229203B (it) Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
ZA906057B (en) 4-(n-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents
ES2009689A6 (es) Procedimiento para preparar derivados de 3-piperidina-carbaldehido-oxima.
GR3006606T3 (es)
AU653802B2 (en) Condensed diazepinones
EP0276805A3 (en) Substituted 3-phenyl-7h-thiazoloû3,2-b¨û1,2,4¨triazin-7-ones, processes for their preparation, medicaments containing them and their use as well as some of the intermediates obtained during the preparation of said compounds
ES2008421A6 (es) Procedimiento para la obtencion de derivados de la pilocarpina.
DK0950053T3 (da) Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 628548

Country of ref document: ES